Red wine, grapes, and better health-resveratrol

Nutrition in Clinical Practice

Volumn 26, Issue 6, 2011, Pages 722-723

  Mullin, Gerard E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPHENOL; RESVERATROL;

ANTIINFLAMMATORY ACTIVITY; CHRONIC INFLAMMATION; DIET; DIETARY INTAKE; GRAPE; HUMAN; NONHUMAN; PHYTOCHEMISTRY; RED WINE; REVIEW;

ANTI-INFLAMMATORY AGENTS; HUMANS; OXIDATIVE STRESS; PLANT EXTRACTS; POLYPHENOLS; STILBENES; VITIS; WINE;

VITIS VINIFERA;

EID: 84855184943     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533611423927     Document Type: Review

References (25)

1. Shapiro H, Singer P, Halpern Z, Bruck R. Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis. Gut. 2007 ; 56 (3). 426-435 (Pubitemid 46579775)
2. Athar M, Back JH, Tang X, et al. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol. 2007 ; 224 (3). 274-283 (Pubitemid 47575677)
3. Block G, Jensen CD, Norkus EP, et al. Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study. Nutr J. 2007 ; 6: 30
4. Rodrigo R, Miranda A, Vergara L. Modulation of endogenous antioxidant system by wine polyphenols in human disease. Clin Chim Acta. 2011 ; 412 (5-6). 410-424
5. Das S, Das DK. Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets. 2007 ; 6 (3). 168-173 (Pubitemid 47455785)
6. Martin AR, Villegas I, La Casa C, de la Lastra CA. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem Pharmacol. 2004 ; 67 (7). 1399-1410 (Pubitemid 38315105)
7. Martin AR, Villegas I, Sanchez-Hidalgo M, de la Lastra CA. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br J Pharmacol. 2006 ; 147 (8). 873-885
8. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006 ; 5 (6). 493-506 (Pubitemid 44136961)
9. Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS. Resveratrol-associated renal toxicity. Toxicol Sci. 2004 ; 82 (2). 614-619 (Pubitemid 39600090)
10. Petrovski G, Gurusamy N, Das DK. Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci. 2011 ; 1215: 22-33
11. Kaminski BM, Steinhilber D, Stein JM, Ulrich S. Phytochemicals resveratrol and sulforaphane as potential agents for enhancing the anti-tumor activities of conventional cancer therapies. Curr Pharm Biotechnol. 2011 ;:
12. Udenigwe CC, Ramprasath VR, Aluko RE, Jones PJ. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev. 2008 ; 66 (8). 445-454
13. Bruno R, Ghisolfi L, Priulla M, Nicolin A, Bertelli A. Wine and tumors: study of resveratrol. Drugs Exp Clin Res. 2003 ; 29 (5-6). 257-261 (Pubitemid 38568632)
14. Park JW, Choi YJ, Jang MA, et al. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells. Cancer Lett. 2001 ; 163 (1). 43-49
15. Jazirehi AR, Bonavida B. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther. 2004 ; 3 (1). 71-84 (Pubitemid 39193680)
16. Dulak J. Nutraceuticals as anti-angiogenic agents: hopes and reality. J Physiol Pharmacol. 2005 ; 56 (suppl 1). 51-67 (Pubitemid 44922295)
17. Walter RB, Brasky TM, Milano F, White E. Vitamin, mineral, and specialty supplements and risk of hematologic malignancies in the prospective VITamins And Lifestyle (VITAL) study. Cancer Epidemiol Biomarkers Prev. 2011 ;:
18. Fonar Y, Frank D. FAK and WNT signaling: the meeting of two pathways in cancer and development. Anticancer Agents Med Chem. 2011 ;:
19. Nguyen AV, Martinez M, Stamos MJ, et al. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res. 2009 ; 1: 25-37
20. Jones SB, DePrimo SE, Whitfield ML, Brooks JD. Resveratrol-induced gene expression profiles in human prostate cancer cells. Cancer Epidemiol Biomarkers Prev. 2005 ; 14 (3). 596-604 (Pubitemid 40489201)
21. Sonnett TE, Levien TL, Gates BJ, Robinson JD, Campbell RK. Diabetes mellitus, inflammation, obesity: proposed treatment pathways for current and future therapies. Ann Pharmacother. 2010 ; 44 (4). 701-711
22. Brasnyó P, Molnár GA, Mohás M, et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr. 2011 ; 106 (3). 383-389
23. Darvesh AS, Carroll RT, Bishayee A, Geldenhuys WJ, Van der Schyf CJ. Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Expert Rev Neurother. 2010 ; 10 (5). 729-745
24. Petro TM. Regulatory role of resveratrol on Th17 in autoimmune disease. Int Immunopharmacol. 2011 ; 11 (3). 310-318
25. Beaudeux JL, Nivet-Antoine V, Giral P. Resveratrol: a relevant pharmacological approach for the treatment of metabolic syndrome?. Curr Opin Clin Nutr Metab Care. 2010 ; 13 (6). 729-736